Healthcare & Life Sciences

The Netherlands: Europe’s Most Attractive Life Sciences Hotspot, or the Next Big Troublemaker?

July 1, 2019
Healthcare & Life SciencesPublic & Government Affairs

The Netherlands certainly has a lot going for it when it comes to attracting the world’s leading biopharmaceutical companies: World-class research institutes, a well-respected healthcare system and not least of all the new home of the European Medicines Agency.

FTI Consulting Brussels and IvCB explore whether there is another side to the story. Read more here- A New Healthcare Hotspot?

Related Articles

A Year of Elections in Latin America: Navigating Political Cycles, Seizing Long-term Opportunity

January 23, 2024—Around 4.2 billion people will go to the polls in 2024, in what many are calling the biggest electoral year in history.[...
Navigating the Summer Swing: Capitalizing on the August Congressional Recess

July 15, 2024—Since the 1990s, federal lawmakers have leveraged nearly every August to head back to their districts and reconnect with...
Protected: Walking the Tightrope: Navigating Societal Issues on Social Media 

July 13, 2024—There is no excerpt because this is a protected post.
Retail Shareholders: The New Frontier of Shareholder Engagement

July 12, 2024—Retail investors now account for 25% of daily fund flows,[1] making them a significant variable in the value equation fo...